Molina Healthcare, Inc

MOH Healthcare Healthcare Plans

Molina Healthcare, Inc’s revenue for fiscal 2025 (year ended December 2025) was $45.4 billion, up 11.7% from fiscal 2024. In the quarter to June 2026, revenue fell 4.84%, EPS fell 75.0%, free cash flow grew 5.81% and total debt rose 10.9%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

209.87 5.51 +2.70%
Market cap
$10.9B
P/E
0.0×
Fwd P/E
55.0×
Dividend yield
—
F-score
4/9
Altman Z
4.28
Beneish M
−1.99
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
58.10 0.00 11.00 11.83 18.94 28.27 23.54 19.78 14.25 20.27
Piotroski F-Score
4 3 5 4 5 6 8 8 5 4
Altman Z-Score
3.21 2.82 4.50 4.88 4.06 4.27 4.77 4.53 4.60 4.28
P/S ratio
0.17 0.22 0.38 0.50 0.65 0.66 0.58 0.63 0.41 0.20
P/FCF ratio
5.97 6.08 0.00 22.39 6.88 9.00 27.03 13.59 30.71 0.00
Altman Z″-Score (non-manufacturers)
2.18 1.38 3.87 4.92 3.70 3.11 3.43 3.90 4.06 3.60
Beneish M-Score
(2.29) (3.45) (1.48) (2.06) (2.55) (2.59) (2.41) (2.41) (2.15) (1.99)
P/Operating CF
74.22 (28.55) (57.64) 234.44 9.66 30.80 (86.95) (31.07) (74.58) (30.75)
P/B ratio
1.80 3.27 4.30 4.31 5.99 6.99 6.22 5.09 3.72 2.25
Price to Tangible BV
3.34 4.04 4.87 4.72 10.86 13.34 11.71 7.75 6.53 4.89
EV/Sales
0.00 0.03 0.21 0.33 0.46 0.47 0.42 0.43 0.27 0.11
EV/EBITDA
0.08 0.00 3.21 4.88 7.63 11.44 9.89 8.45 5.74 5.00
EV/Operating CF
0.05 0.82 (12.87) 12.74 4.69 6.21 17.26 8.87 16.87 (9.13)
EV/FCF
0.07 0.92 (11.75) 14.66 4.88 6.45 19.57 9.34 19.97 (7.68)
Quick Ratio
1.22 1.21 1.37 1.78 1.55 1.39 1.43 1.50 1.56 1.60
Current Ratio
1.31 1.35 1.52 1.83 1.59 1.43 1.47 1.54 1.62 1.69
Net Debt/EBITDA
(6.01) 10.75 (2.42) (2.59) (3.15) (4.56) (3.79) (3.85) (3.10) (4.41)
Debt/Assets
22.08% 25.61% 20.38% 21.63% 24.67% 19.59% 19.42% 16.02% 19.95% 25.38%
Debt/Equity
1.00 1.62 0.89 0.75 1.12 0.91 0.81 0.57 0.69 0.97
Asset Turnover
2.54 2.50 2.42 2.41 2.38 2.55 2.61 2.50 2.66 2.91
Operating CF/Net income
12.94 (1.57) (0.44) 0.59 2.82 3.22 0.98 1.52 0.55 (1.13)
Capex/Depreciation
(0.97) (0.41) (0.24) (0.64) (0.84) (0.59) (0.52) (0.49) (0.54) (0.52)
Interest Coverage
3.03 (4.70) 9.83 12.00 10.57 8.50 10.66 14.43 14.47 4.07
ROE
3.24% (34.29%) 47.39% 40.86% 33.19% 27.89% 28.32% 30.39% 27.07% 11.02%
ROA
0.74% (6.43%) 9.05% 10.57% 8.25% 6.06% 6.46% 8.02% 7.73% 3.03%
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Tangible Assets
2.78% (22.30%) 28.77% 23.91% 20.38% 19.31% 22.71% 23.49% 22.83% 8.78%
Average Days of Receivables
20.79 15.99 25.70 30.49 31.42 28.61 26.28 33.25 29.62 28.39
Research and Development Expense of Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Selling, General and Administrative Expense of Revenue
7.83% 8.02% 7.06% 7.70% 7.62% 7.45% 7.23% 7.23% 6.75% 6.62%
Intangible Assets out of Total Assets
0.10 0.03 0.03 0.03 0.10 0.10 0.11 0.10 0.12 0.14
Share Based Compensation of Revenue
0.15% 0.23% 0.14% 0.23% 0.29% 0.26% 0.32% 0.34% 0.29% 0.10%
Graham Net Nets
0.06 0.09 0.13 0.14 0.04 0.03 0.04 0.09 0.10 0.10
Graham Number
24.85 0.00 80.13 90.18 94.74 107.32 125.04 175.69 189.75 121.83
Earnings Yield
1.72% (11.56%) 9.09% 8.45% 5.28% 3.54% 4.25% 5.05% 7.02% 4.93%
Free Cash Flow Yield
16.74% 16.44% (4.85%) 4.47% 14.54% 11.11% 3.70% 7.36% 3.26% (6.94%)
Revenue per Share
320.97 355.05 309.67 270.56 329.20 480.47 553.18 590.50 708.19 860.34
Operating CF per Share
12.15 14.36 (5.15) 6.98 32.17 36.66 13.37 28.80 11.22 (10.13)
Capex per Share
(3.18) (1.54) (0.49) (0.92) (1.25) (1.33) (1.57) (1.46) (1.74) (1.91)
Free Cash Flow per Share
8.97 12.82 (5.64) 6.06 30.92 35.33 11.80 27.35 9.48 (12.05)
Cash per Share
82.62 104.98 73.89 70.71 102.19 132.18 129.84 157.83 156.57 156.36
Shareholders Equity per Share
29.77 23.88 27.00 31.51 35.53 45.50 51.28 73.05 78.33 77.06
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
29.77 23.88 27.00 31.51 35.53 45.50 51.28 73.05 78.33 77.06
Free Cash Flow
497.00 718.00 (344.00) 377.00 1,824.00 2,042.00 682.00 1,578.00 544.00 (636.00)
Working Capital
1,418.00 1,954.00 2,216.00 2,698.00 2,911.00 3,017.00 3,229.00 4,374.00 4,877.00 5,072.00
Capital Expenditures
(176.00) (86.00) (30.00) (57.00) (74.00) (77.00) (91.00) (84.00) (100.00) (101.00)
Net Current Asset Value
188.00 377.00 955.00 1,140.00 440.00 485.00 734.00 1,865.00 1,639.00 949.00
EV/EBIT
0.12 0.00 3.57 5.29 8.25 12.90 11.38 9.37 6.36 6.25
Capex to Sales
0.01 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Operating Income
9.70 0.00 6.27 8.08 11.64 18.02 15.71 13.63 9.79 11.73
Other line items
Depreciation/Fixed assets
0.40 0.61 0.53 0.23 0.23 0.33 0.68 0.63 0.65 0.65
Cash ROIC
6.31% 7.65% (4.52%) 4.82% 17.41% 16.13% 5.30% 10.05% 3.28% (3.91%)
Accounts Receivable Turnover
21.91 21.11 17.16 12.30 12.62 14.43 14.28 12.61 12.70 13.30
Accounts Payable Turnover
40.85 46.78 41.01 31.18 27.68 31.97 31.40 26.78 26.66 32.58
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Days of Payables
9.21 7.61 9.18 13.18 14.79 12.97 11.94 15.94 14.11 10.10
Days of Inventory on Hand
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Average Receivables
811.50 942.00 1,100.50 1,368.00 1,539.00 1,924.50 2,239.50 2,703.00 3,201.50 3,416.00
Average Payables
373.50 375.50 378.00 446.00 571.50 741.50 865.50 1,070.50 1,291.50 1,212.00
Average Assets
7,012.50 7,960.00 7,812.50 6,970.50 8,159.50 10,870.50 12,261.50 13,603.00 15,261.00 15,597.00
Average Common Equity
1,603.00 1,493.00 1,492.00 1,803.50 2,028.00 2,363.00 2,797.00 3,589.50 4,355.50 4,282.50

Fold the line items

Columns are period end dates